PT - JOURNAL ARTICLE AU - Aruffo, Elena AU - Yuan, Pei AU - Tan, Yi AU - Gatov, Evgenia AU - Moyles, Iain AU - Bélair, Jacques AU - Watmough, James AU - Collier, Sarah AU - Arino, Julien AU - Zhu, Huaiping TI - Mathematical modeling of vaccination rollout and NPIs lifting on COVID-19 transmission with VOC: a case study in Toronto, Canada AID - 10.1101/2021.08.11.21261932 DP - 2021 Jan 01 TA - medRxiv PG - 2021.08.11.21261932 4099 - http://medrxiv.org/content/early/2021/08/13/2021.08.11.21261932.short 4100 - http://medrxiv.org/content/early/2021/08/13/2021.08.11.21261932.full AB - Background Since December 2020, public health agencies have implemented a variety of vaccination strategies to curb the spread of SARS-CoV-2, along with pre-existing Nonpharmaceutical Interventions (NPIs). Initial strategy focused on vaccinating the elderly to prevent hospitalizations and deaths. With vaccines becoming available to the broader population, we aimed to determine the optimal strategy to enable the safe lifting of NPIs while avoiding virus resurgence.Methods We developed a compartmental deterministic SEIR model to simulate the lifting of NPIs under different vaccination rollout scenarios. Using case and vaccination data from Toronto, Canada between December 28, 2020 and May 19, 2021, we estimated transmission throughout past stages of NPI escalation/relaxation to compare the impact of lifting NPIs on different dates on cases, hospitalizations, and deaths, given varying degrees of vaccine coverages by 20-year age groups, accounting for waning immunity.Results We found that, once coverage among the elderly is high enough (80% with at least one dose), the main age groups to target are 20-39 and 40-59 years, whereby first-dose coverage of at least 70% by mid-June 2021 is needed to minimize the possibility of resurgence if NPIs are to be lifted in the summer. While a resurgence was observed for every scenario of NPI lifting, we also found that under an optimistic vaccination coverage (70% by mid-June, postponing reopening from August 2021 to September 2021can reduce case counts and severe outcomes by roughly 80% by December 31, 2021.Conclusions Our results suggest that focusing the vaccination strategy on the working-age population can curb the spread of SARS-CoV-2. However, even with high vaccination coverage in adults, lifting NPIs to pre-pandemic levels is not advisable since a resurgence is expected to occur, especially with earlier reopening.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the One Health Modelling Network for Emerging Infections (OMNI), a Canadian NSERC and PHAC Emerging Infectious Diseases Modelling Initiative (HZ, EA, PY, YT, IM, JA, JB, JW). This research was also supported by the Canadian Institutes of Health Research (CIHR), Canadian COVID-19 Math Modelling Task Force (JA, JB, JW, HZ), the Natural Sciences and Engineering Research Council of Canada (JA, JB, JW, IM, HZ) and York University Research Chair program (HZ).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used is available in the manuscript. https://github.com/EAruffo/Covid_vaccine_NPIs_paper